By stabilizing m6A-modified YY1 mRNA, increasing the transcription of miR-27a-3p, and favorably regulating TUG1, YY1 influenced drug sensitivity, apoptosis, and proliferation in MM (86). The gene discussed is TUG1; the disease is Miyoshi myopathy.